Novo Nordisk A/S reports progress on its DKK 15 billion share repurchase program, having repurchased 9,967,992 B shares worth DKK 2.59 billion since February 4, 2026.
Key takeaways
Novo Nordisk initiated a share repurchase program of up to DKK 15 billion over 12 months starting February 4, 2026.
The company repurchased 9,967,992 B shares worth DKK 2,586,404,548 at an average price of DKK 259.47 per share as of April 1, 2026.
Novo Nordisk currently holds 27,357,791 B shares as treasury shares, representing 0.6% of the total share capital.
The company expects to repurchase B shares for up to DKK 3.8 billion in the period from February 4, 2026 to May 4, 2026.